Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Oaktree Acquisition Corp. III Life Sciences Files Q2 2026 10-Q

Oaktree Acquisition Corp. III Life Sciences filed its quarterly report on Form 10-Q with the SEC on August 12, 2026, covering the quarter ended June 30, 2026, and reporting net income of $1,604,621 for the three-month period.

Nitish Kishor | 12 August 2026

National Bankshares Reports Q2 2026 Financial Results

National Bankshares, Inc. filed its Form 10-Q with the Securities and Exchange Commission on August 12, 2026, reporting unaudited financial results for the quarterly and six-month periods ended June 30, 2026.

Nitish Kishor | 12 August 2026

Daily Journal Corporation Reports Q3 2026 Results

Daily Journal Corporation filed its Form 10-Q with the SEC on August 12, 2026, covering the quarterly period ended June 30, 2026, and reporting a net loss driven primarily by unrealized losses on its marketable securities portfolio.

Manish Choudhary | 12 August 2026

Resideo Technologies Posts Q2 2026 Financial Results

Resideo Technologies, Inc. filed its Form 10-Q with the SEC on August 12, 2026, covering the quarterly period ended July 4, 2026, reporting net income of $97 million for the second quarter and $135 million for the first half of the fiscal year.

Nitish Kishor | 12 August 2026

Sizzle Acquisition Corp. II Files Q2 2026 10-Q

Sizzle Acquisition Corp. II filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 12, 2026.

Anjali Anand | 12 August 2026

American Exceptionalism Acquisition Corp. A Files Q2 2026 10-Q

American Exceptionalism Acquisition Corp. A (NYSE:AEXA) filed its quarterly report on Form 10-Q for the quarter ended June 30, 2026, reporting net income of $5,733,720 for the six-month period and total assets of $355,066,789 as of that date.

Manish Choudhary | 12 August 2026

Soulpower Acquisition Corporation Files Q2 2026 10-Q

Soulpower Acquisition Corporation filed its quarterly report on Form 10-Q for the quarter ended June 30, 2026, disclosing financial results and balance sheet data for the blank-check company listed on the New York Stock Exchange.

Vinay Lochav | 12 August 2026

Atea Pharmaceuticals Files Q2 2026 Form 10-Q

Atea Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended June 30, 2026, disclosing its financial position, share count, and ongoing clinical development activities as of that date.

Manish Choudhary | 12 August 2026

Turn Therapeutics Reports Q2 2026 Financial Results

Turn Therapeutics Inc. filed its quarterly report on Form 10-Q with the SEC on August 12, 2026, covering the three- and six-month periods ended June 30, 2026.

Shwetambri Chauhan | 12 August 2026

Activate Energy Acquisition Corp. Files Q2 2026 10-Q

Activate Energy Acquisition Corp. filed its quarterly report on Form 10-Q for the quarter ended June 30, 2026, with the SEC on August 12, 2026, disclosing financial results for its first full half-year of operations as a blank-check company listed on NASDAQ:AEAQ.

Anjali Anand | 12 August 2026
Support

Hi! How can we help you today?

Loading…